Menu

Hepato-Pancreato-Biliary (HPB)

Hepato-pancreato-biliary cancers include malignant or cancerous tumours originating in the cells of the liver, bile ducts, and gallbladder.

The overall aims of the HPB ECAG are to provide specialist advice and guidance to the East Midlands Cancer Clinical Network Steering Group, Clinical Commissioning Groups, and NHS England Specialist Commissioners on the standards of service for patients with hepatobiliary cancer, reflecting current best practice and opportunities for development.

The HPB ECAG aims to ensure that patients with hepato-pancreato-biliary cancer receive high quality equitable cancer care throughout the East Midlands Cancer Clinical Network, regardless of geography or socio-economic factors, and will, wherever possible, endeavour to improve the standard of care provided.

Presently, the HPB ECAG is focused on the issues of early diagnosis of pancreatic cancer to determine if there are region-wide themes that can be explored further.  In addition, the ECAG is looking at the distribution of services and personnel across the East Midlands to identify common weaknesses and develop unified methods of addressing these shortfalls.

The group hopes to enhance collaboration across the East Midlands from all groups involved in the patient pathway including primary, secondary and tertiary care.  The ultimate aim is to create a true network of committed health professionals who will benefit from their shared experiences in ensuring the best possible pathway for their patients.

Lead
Mr Giuseppe Garcea
Consultant Hepato-Pancreato-Biliary Surgeon
University Hospitals of Leicester NHS Trust

Future meeting dates
Wednesday 6th September 2017

Key documents
pdfAnnual Report 2016/17
pdfClinical guidelines (updated December 2016)